Saw Palmetto and Reduced Nocturia

• Serenoa repens for benign prostatic hyperplasia.

  • 2012-12-12
  • Meta-Analysis · n = 5,666
  • The Cochrane database of systematic reviews 12
  • • James Tacklind
    • Roderick Macdonald
    • Indy Rutks
    • Judith U Stanke
    • Timothy J Wilt

  • PubMed: 23235581
  • DOI: 10.1002/14651858.cd001423.pub3

  5 Insights on

  • Reduced Nocturia

  • High evidence
  • Clinical

  versus placebo, SR did not significantly decrease nightly urination on the AUA Nocturia scale (range zero to five) at 72 weeks follow-up (one-sided P = 0.19).

  Effect

  Neutral

  Effect size

  Small

  Significant

  No

  Dose

  not specified for this outcome (trial with 369 men)

• Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.

  • 2019-10-02
  • Review
  • Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 91(3)
  • • Arrigo F G Cicero
    • Olta Allkanjari
    • Gian Maria Busetto
    • Tommaso Cai
    • Gaetano Larganà
    • Vittorio Magri
    • Gianpaolo Perletti
    • Francesco Saverio Robustelli Della Cuna
    • Giorgio Ivan Russo
    • Kostantinos Stamatiou
    • Alberto Trinchieri
    • Annabella Vitalone

  • PubMed: 31577095
  • DOI: 10.4081/aiua.2019.3.139

  11 Insights on

  • Reduced Nocturia

  • Low evidence

  Recent meta-analyses found the effectiveness of Serenoa repens similar or inferior of that of finasteride and tamsulosin but clearly higher than that of placebo in the treatment of mild and moderate low urinary tract symptoms (LUTS), nocturia and discomfort.

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes